Gamida Cell Ltd

Activities: Research & Development Pharmaceutical

Trending Articles

  1. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  2. Precision psychiatry in action: How IMed Consultancy helped HMNC Brain Health’s Cortibon programme AI-driven approach promises a new class of depression treatment
  3. Aesica leads market in production of flurbiprofen A drug used to treat the pain and inflammation associated with arthritis
  4. How to avoid sticking and picking in the tableting industry John Norman and Kevin Queensen of Natoli Engineering explain
  5. The new F-Gas Regulation and its impact on pharmaceutical freeze-drying Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex,...

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Manufacturing

Gamida extends Lonza partnership beyond clinical to commercial

Agreement is in preparation for potential FDA approval of Gamida’s cell therapy candidate
Research & Development

Novartis to invest US$35m in Gamida Cell

Swiss pharmaceutical giant will take 15% stake and has an option to buy the company
Research & Development

Novel paths to treating rare diseases

Biotechnology is providing new pathways to treatments for many uncommon yet life-threatening diseases. Dr Sarah Houlton looks at some promising candidates
Subscribe now